Cara Therapeutics Inc (CARA)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current CARA market cap is 20.2M. The company's latest EPS is USD -2.1676 and P/E is -0.17.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.17M | 6.93M | 4.87M | 3M | 2.14M |
| Operating Income | -27.65M | -32.34M | -28.9M | -32.61M | -29.67M |
| Net Income | -26.67M | -31.48M | -28.03M | -32.34M | -30.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 19.89M | 135.08M | 23.03M | 41.87M | 20.97M |
| Operating Income | -111.68M | 5.39M | -89.08M | -87.54M | -121.5M |
| Net Income | -106.37M | 8.41M | -88.44M | -85.47M | -118.51M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 153.28M | 134.39M | 115.34M | 125.84M | 90.1M |
| Total Liabilities | 16.68M | 25.46M | 29.7M | 68.76M | 60.3M |
| Total Equity | 136.6M | 108.93M | 85.64M | 57.09M | 29.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 232.96M | 271.16M | 247.06M | 182.24M | 125.84M |
| Total Liabilities | 46.25M | 22.16M | 19.53M | 23.46M | 68.76M |
| Total Equity | 186.71M | 249M | 227.52M | 158.78M | 57.09M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -34.62M | -55.06M | -74.71M | -92.08M | -30.45M |
| Investing | 17.71M | 50.51M | 73.67M | 43.46M | 25.95M |
| Financing | 560k | 560k | 1.68M | 38.15M | -836k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -109.23M | -5.49M | -60.09M | -78.73M | -92.08M |
| Investing | -30.52M | -20.28M | -4.75M | 128.71M | 43.46M |
| Financing | 142.6M | 39.14M | 46.61M | 311k | 38.15M |
| Market Cap | 20.2M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 0.96 |
| Price to Cash Ratio | 0.39 |
| Price to Book Ratio | 0.35 |
| Dividend Yield | - |
| Shares Outstanding | 54.68M |
| Average Volume (1 week) | 878.75k |
| Average Volume (1 Month) | 1.5M |
| 52 Week Change | -87.39% |
| 52 Week High | 3.45 |
| 52 Week Low | 0.24 |
| Spread (Intraday) | 0.02 (4.82%) |
| Company Name | Cara Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.caratherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
